The authors describe how room temperature storage of a 1120-member compound library prepared in either DMSO or in a hydrated-DMSO/water (67/33) mixture affects the reproducibility of potency values as monitored using cytochrome P450 1A2 and 2D6 isozyme assays. The bioluminescent assays showed Z′ factors of 0.71 and 0.62, with 17% and 32% of the library found as active against the CYP 1A2 and 2D6 isozymes, respectively. The authors tested the library using quantitative high-throughput screening to generate potency values for every library member, which was measured at 7 time intervals spanning 37 weeks. They calculated the minimum significant ratio (MSR) from these potency values at each time interval and found that for the library stored in DMSO, the CYP 1A2 and 2D6 assay MSRs progressed from approximately 2.0 to 5.0. The hydrated conditions showed similar performance in both MSR progression and analytical quality control results. Based on this study, the authors recommend that DMSO samples be stored in 1536-well plates for <4 months at room temperature. Furthermore, the study illustrates the degree and time scale of apparent compound potency changes due to sample storage. (Journal of Biomolecular Screening 2009:538-546) 
INTRODUCTION

C
ompound library storage conditions must be amenable both to maintaining compound integrity and the availability to screening operations. Studies of library storage conditions have focused on analytical chemistry methods, namely, liquid chromatography coupled with mass spectrometry (LC-MS), to characterize the integrity of chemical libraries stored at industrial high-throughput screening (HTS) facilities. [1] [2] [3] [4] [5] [6] [7] An overview of compound management by Chan and Hueso-Rodríguez 8 and a historical perspective by Archer 9 stated that storage of compound libraries in DMSO, in practice, falls into 1 of 4 strategies: ambient, +4 °C in a desiccated inert atmosphere to control water content and ensure liquid solution storage; +4 °C with humidity control to encourage frozen solution storage; and -20 °C in a desiccated atmosphere to ensure frozen solution storage and prevent ice buildup. In an experimental survey of compound storage issues, Cheng and others 2 monitored a collection of 644 compounds in DMSO under different temperature, water content, and atmospheric conditions and examined effects of freeze-thaw cycles. In this study, no significant loss of compound was detected after multiple freezethaw cycles when performed in a dry nitrogen environment, but samples stored in the presence of 5% water were less stable. A pair of articles from Procter and Gamble found that the probability of observing a compound by LC-MS decreased 48% after 1 year of storage in DMSO under ambient conditions, and the amount of compound detected reduced linearly with increased freeze-thaw cycles. 6, 7 These studies have pointed to compound precipitation, augmented by both DMSO water content and freeze-thaw cycles, as one of the most important factors in determining compound library quality during storage. 10 Measurements of purity within compound libraries have also been examined. Bowes and others 1 conducted a 3-year stability study of representative compounds from the Biogen Idec library, which demonstrated greater stability of lyophilized samples compared with 10-mM DMSO stock solutions stored at 4 °C. Ilouga and others 5 studied a representative subset of the Evotec library and predicted that in 4 years, the mean purity of the compound collection would decrease by about half in ambient liquid storage, whereas storage in frozen solutions would show more optimal results (<20%). In these studies, initial sample purity and storage in noninert gas atmosphere were identified as factors in the decay of compounds and supported that compound degradation is a concern in long-term storage (>1 year). the manner in which an HTS assay campaign may be affected by these changes has not been addressed to date. Such an analysis would demonstrate how changes in compound quality over time are detected in a bioassay and provide additional guidelines for compound preparation during HTS or lead optimization studies. Therefore, we monitored the integrity of a compound library under ambient conditions using 2 robust bioassays over a period of 37 weeks. A typical HTS assay will show activity against only a small percentage (typically <1%) of the library. In our study, to ensure broad coverage of the chemical library, we used cytochrome P450 (CYP) isozymes. These enzymes have evolved to act as molecular incinerators in the liver and are known to interact with a wide range of substrates, making CYP assays ideal tools for quality assessment of diverse sets of compounds. In this study, we employed CYP 1A2 and 2D6 isozymes because we have previously confirmed that these assays perform well in 1536-well microplate formats, show low sensitivity to DMSO, 11, 12 and are inhibited by a large number of compounds in typical compound collections (see PubChem AIDs 410 and 891, respectively). We examined compound storage in 1536-well microplates because this is central to our screening platform. Furthermore, we used conditions that did not require investment in high-end storage units to make the study more comparable with what may be found in many academic screening laboratories that have proliferated in recent years. 13, 14 The method of quantitative HTS (qHTS) 15, 16 was used to generate concentration-response curves (CRCs) for every library compound at each time point. Our endpoints monitored how potency, efficacy, and area under the curve (AUC) changed with compound storage time. In addition to an expected decrease in potency over time, we also found lower reproducibility of potency values and lower efficacy in older compound samples. We further examined the compound library using LC-MS in an attempt to address reasons why the potency of some compounds changed significantly over time. Based on this study, we recommend ambient storage of 1536-well compound plates at room temperature for <4 months for screening collections.
MATERIALS AND METHODS
Reagents
The luciferase-based P450-Glo Screening Systems were obtained from Promega (Madison, WI). The CYP 1A2 (cat no. V9770) and CYP 2D6 (cat no. V9890) screening systems were used in this study. DMSO and other solvents were analytical grade (Fisher ACS grade).
Preparation of compound libraries and control plates
The 1120 compounds were from Prestwick Chemical Inc. (Illkirch, France). Upon receipt, our compound management team subdivided a portion of the library into multiple, identical 384-well stock plates with 70 µL stock solution per well, which were then heat sealed and stored at low temperature (-80 °C). A single stock plate set of the Prestwick library from the same supplied batch was retrieved from low-temperature storage, thawed, and split into 2 copies. Interplate dilution series were prepared as described previously 15 11.4 µM to 1.6 nM). After preparation of the working libraries, the remaining compound solutions in the 384-well plate sets were heat sealed and placed back into the freezer at -80 °C below the glass transition temperature for the DMSO eutectic. 18 These frozen 384-well copies are called "stored copies" throughout. These 384-well stored plate sets were thawed at the end of the experiment and characterized using CYP isozyme assays, and quality control (QC) was performed by LC-MS. To QC the working libraries, the highest-concentration plate (2000 µM) was reformatted into 384-well plates for compatibility with the LC-MS system. In addition, an unused 384-well copy from the same supplied batch was retrieved from low-temperature storage and characterized (this is referred to as the "supplied set").
qHTS and storage conditions
After assaying the compound libraries on the initial day of the experiment (week 0), assays were repeated at elapsed times of 7, 42, 77, 105, 133, and 258 days or 1, 6, 11, 15, 19, and 37 weeks following the initial measurements. Working compound 1536-well library plates at the NIH Chemical Genomics Center (NCGC) are stored with Kalypsys lids, on revolving storage decks at room temperature, in ambient atmosphere. 17, 19 The working copies of the library using either DMSO or the hydrated-DMSO mixture were repeatedly accessed using a pin tool 20 at each time point of the assays.
Cytochrome P450 assays
Bioluminescent assays for CYP isozymes were based on conversion of a pro-luciferin substrate to D-luciferin, the substrate for firefly luciferase. 21, 22 These assays were miniaturized to 1536-well plates using a protocol in which 2 µL of enzyme and the pro-luciferin substrate was added for final concentrations of either 10 nM or 5 nM enzyme (CYP 1A2 or 2D6, respectively). Either 100 µM or 30 µM of the pro-luciferin substrates Luc-ME (CYP 1A2) or Luc-ME EGE (CYP 2D6) was used in the assays. Using a pin tool, 23 nL of compound was added to the assay wells. 19, 20 The CYP enzyme reaction was then started by adding 2 µL of NADPH regeneration solution supplied by Promega (Madison, WI). Following 1-h incubation at room temperature, 4 µL of the luciferin detection reagent was added. After 20 min, the luminescence signal was measured on a Perkin Elmer (Waltham, MA) ViewLux using a 60-s exposure time with 2× binning of the image pixels.
For the assays, controls were added from a separate 1536-well compound plate as follows: columns 1 and 2, 16-point titrations in duplicate of furafylline for CYP 1A2 or quinidine for CYP 2D6 (final starting assay concentration was 57 µM or 1.4 µM, respectively, 1:2 dilutions were used in titration series); column 3, the neutral control (DMSO); and column 4 was an IC 100 concentration of the appropriate control inhibitor.
Calculation of minimum significant ratio (MSR) values
Concentration-response data from each screen were characterized similar to previous reports, 15 using automated curvefitting software developed at the NCGC, available on the NCGC Web site. 23 In brief, the software fits the data using a residual error minimization algorithm with automatic outlier determination to a 4-parameter Hill equation to obtain IC 50 values. Apparent stimulators of P450 activity were minimal in both the CYP 1A2 and 2D6 assays and showed weak activity that was treated here as inactive.
To ascertain the useable lifetime of the compound libraries, we calculated the MSR at each time point for each storage condition. The MSR value provides a reliability index for potency values and represents the smallest potency ratio between 2 determinations that is significant. Lower reproducibility of potency values will be reflected by an increase in MSR values. It is important to consider that MSR is derived from the log of IC 50 values; so, for example, with an MSR of 5.0 and a measured potency of 1 µM, one would not be able to tell if the true potency was 0.2 µM or 5 µM, a 25-fold range. In general, an MSR ≤3 is acceptable for a primary screening assay. [24] [25] [26] Intrarun control-compound MSR values were calculated as described elsewhere, 27 using the intrarun MSR formula. Mean ratios (MRs) were also calculated at each time point as a measure of overall drift in apparent potency of the libraries:
where d  is the average of the differences in log potency. If a library is apparently less potent overall than it was in the initial measurement, at that time point MR will be less than 1. Compounds with activity ratios greater than (LSA ( + ) = MR*MSR) or less than (LSA (-) = MR/MSR) the limits of statistical agreement (LSA) were identified as outliers. The week 0 to week 1 MSR value was used with the MR from the time-spaced replicate of interest to set the LSA values.
As an additional test of library integrity, changes in compound assay performance were calculated by Riemann summation of the AUC for each CRC.
Analytical chemistry
Chromatography was performed on a Waters LC-MS system using MassLynx software. A BEH C18 column (1.7 µm, 2.1 × 50 mm) was heated to a temperature of 45 °C at a flow rate of 0.5 mL/min. A linear gradient from 2% to 100% acetonitrile over 1.3 min with a run time of 2.1 min was used. The mobile phase consisted of acetonitrile (0.025% trifluoroacetic acid) and high-performance liquid chromatography-grade water (0.05% trifluoroacetic acid). Quantitation was determined by evaporative light-scattering detector (ELSD; Waters, Milford, MA) and ultraviolet absorbance (UV). Identification was determined using a Waters Micromass ZQ mass spectrometer (MS) with electrospray ionization in the positive mode.
Data were analyzed using Waters OpenLynx software. The primary detector for quantification was the ELSD. Following detection by UV, the solvent flow is split with the use of a simple tee with a split ratio between the ELSD/MS of approximately 65/35. The nitrogen flow for the ELSD is controlled at 45 psi, and the drift tube is heated to 50 °C. For compounds with a poor ELSD response, the AUC was determined by UV absorbance at 220 nm. Compounds that did not give sufficient MS signals to determine identity were reported as unknown. Compounds that gave no signal by any detection method were reported as not found.
RESULTS AND DISCUSSION
Chemical library
To evaluate the use of a bioassay system to monitor compound sample integrity, we used the Prestwick library that is available in adequate supply and represents a wellcharacterized set of compounds that is widely used in both pharmaceutical and academic screening laboratories. 28 The Prestwick library contains small molecules, of which 90% are marketed drugs and 10% are bioactive alkaloids that were selected to give a high level of both structural and pharmacological diversity. We have analyzed this library for structural diversity, which suggests that the Prestwick collection is very diverse although more limited in scope because of its size compared with larger compound collections such as those found in PubChem. 29 
Compound activity in the CYP isozyme assays
A large amount of activity was observed for each isozyme in the compound library regardless of preparation conditions. Initially, the CYP 2D6 isozyme showed inhibition by 32% of the library (357 compounds), whereas the CYP 1A2 isozyme was inhibited by 17% of the library (187 compounds). We found 52% of the CYP 1A2 isozyme active set was shared on average with the active set of the CYP 2D6 isozyme and 36% of the CYP 2D6 active set was shared with the CYP 1A2 active set at any time point of the experiment. The average potency of the compounds was found to be near 1 µM for both isozymes (average pIC 50 = 5.8 ± 0.6; calculated using concentration units of mol/L). Overall, both assays provided a large robust data set to evaluate potency values across the time course of the experiment.
CYP isozyme assays show high performance
We evaluated the stability of the CYP isozyme assays themselves by calculating the MSR of control compounds at each time point. For the set of plates used to assay the library prepared in DMSO, titrations of the CYP 1A2 control inhibitor furafylline yielded MSR values that varied from 1.7 to 2.9 over the 37 weeks of the experiment, with pIC 50 s that varied from 6.4 to 5.4. Comparable stability was observed in the plates used to assay the library prepared with hydrated-DMSO, with control compound titrations yielding MSR values that varied between 1.2 and 2.8. The CYP 2D6 isozyme assay also showed good stability, although several anomalous plates caused the control inhibitor titrations of quinidine during the sixth time point measurement to inflate the MSR value to 17.7. However, the CYP 2D6 control inhibitor MSR values at other points of the experiment in both hydrated-DMSO and DMSO working sets ranged between 1.3 and 1.9. The CYP 2D6 isozyme assay also had lower signal-to-background overall and showed a Z′ factor of 0.62, compared with the CYP 1A2 assay, which showed a Z′ factor of 0.71. Overall, the average control MSR value (excluding the 1 inflated point) for both assays was approximately 2.0.
As a further test of reproducibility of the assays, we compared CYP actives determined from an unused (e.g., newly received from compound management) preparation of the library in both CYP assays. The potencies of CYP 1A2 library actives determined in replicate assays of the freshly prepared library copy showed an MSR = 1.9. Similarly, the CYP 2D6 assay showed an MSR = 1.6 using the fresh library copy. This is in agreement with the MSR values obtained from the control compounds mentioned above. Therefore, both CYP isozyme assays showed high performance throughout the time course of the experiment.
Performance of the CYP assays with compound sample storage
We measured the MSR, MR, and AUC for each time point for the libraries prepared in either DMSO or using a hydrated-DMSO mixture. The hydrated-DMSO mixture contained 67%/33% v/v DMSO/water, which was chosen because of its special properties of near maximal viscosity [30] [31] [32] and proximity to the DMSO hydrate/DMSO eutectic, 18, 33 in which compounds are expected to deviate most from ideal solubility. 10, 34, 35 The overall trends in compound library performance as measured by the CYP 1A2 isozyme assayed against the DMSO working copy is shown are Figure 1 . The reproducibility of IC 50 values decreased relative to the initial measurements as the experiment progressed; consequently, the number of outliers increased. For example, in week 1, 5 outlying compounds were initially observed (Fig. 1A) , whereas at the conclusion of the experiment, 36 outliers were observed (Fig. 1B) , out of 51 distinct outliers that appeared during the experiment. In general, compounds decreased in efficacy over time in concert with the decreases in potency (Fig. 1C) . Of the 126 compounds that had apparent CRCs in the initial assay as well as both replicates in the final time point assays, 103 showed a decrease in efficacy and 91 showed a decrease in potency, with 74 demonstrating a simultaneous decrease in potency and efficacy. Also indicative of the overall trend, 109 compounds showed a decrease in Hill AUC. The decrease in IC 50 reproducibility is also reflected by the compound library MSR values, which show a progressive increase from 2.0 in week 1 to 4.5 in week 37 (Fig. 1D) .
Examining both library conditions in the 2 CYP isozyme assays showed a similar trend (Fig. 2) . In all cases, the IC 50 value reproducibility decreased over time, as indicated by increases in MSR values ( Fig. 2A) . In addition, in general for both assays, compound potency decreased over time, as tracked by decreases in the MRs (Fig. 2B) . The MRs represent the initial IC 50 value divided by the IC 50 value at the time point of interest for a compound, averaged over all compounds, such that an MR <1 indicates compounds showing a decrease in potency. After the initial assay, lower MR values were recorded, with an average of 0.84 over 37 weeks. Although the overall trend in MR values is downward, from measurement to measurement, the values did increase at some time points.
When we compared the potency differences between the 2 conditions, we observed that the changes occurred similarly in the 2 working copies. We compared the DMSO and hydrated-DMSO working copies to each other by taking the difference in log potencies between the 2 data sets at each time point for each CYP isozyme assay. For CYP 1A2, the DMSO to hydrated average MR was 0.92 ± 0.20, and for CYP 2D6, the average MR was 0.93 ± 0.12, suggesting similar changes in potency under either storage condition.
The working library prepared in hydrated-DMSO showed only slightly greater variance over time than the DMSO working copy. It is possible that the working copy prepared in DMSO achieved a water content of at least 10% within the first day of preparation, or equilibrated to hydrated conditions, 36 as this can occur within a day in 1536-well plates filled to a starting volume of 2 to 5 µL with 100% DMSO, 37, 38 which would serve to minimize the differences between the 2 working copies. We found that in the CYP 1A2 assay, MSR values increased from 2.0 to 4.5 for the DMSO samples, whereas the hydrated-DMSO samples increased from 2.5 to 5.9. In the CYP 2D6 assay, MSR values increased from 2.5 to 4.7 for the DMSO working samples, with a maximum MSR of 5.3 (with 2.5% to 13.5% of active compounds identified as outliers), whereas the hydrated-DMSO working sample MSR values increased from 2.8 to 6.6. However, both storage conditions showed acceptable MSR values (library MSRs ∼3-fold) up to the 100-day time point, after which IC 50 variability became unacceptable, as did the relative decrease in potency with respect to the starting point. As well, we note that in either condition, a larger number of compounds became inactive after the first 100 days: 96% ± 3% of the original actives were fit to high-quality CRCs on average for the first 100 days, whereas for the last 2 time points, this average dropped to 79% ± 7%.
Summary of analytical QC results
The QC result of the library as received from compound management prepared in DMSO ( Fig. 3A; 77% found) was comparable to the DMSO stored copy ( Fig. 3B; 81% found) , and the 2 stored copies showed a similar percentage of compounds found at the end of the experiment (Fig. 3B, D) . Differences between the 2 working conditions as observed by LC-MS were small. There was little difference in the numbers of compounds found in both the DMSO and hydrated-DMSO working copies: 763 and 786, respectively, at the conclusion of the experiment (approximately 70% found in either copy; Fig.  3C, E) . The number of compounds uncharacterized by LC-MS in either working or stored hydrated conditions, n = 212, and those with an apparent increase in purity, n = 51, were comparable to the DMSO-working copy. However, the number of compounds showing >95% purity was higher in the hydrated-DMSO working copy (52%) than in the DMSO-working copy (41%). In contrast, both working libraries conditions showed a reduction in compound QC compared with the DMSO stored copies.
In a recent publication by Engeloch and others, 37 duplicate copies of a 2-mM, 1404-member compound library were stored in a 90/10 DMSO/water mixture at 4 °C and observed sequentially over a 24-month period. This article found that 85% of samples were found in excess of 85% pure-comparable with the values found for the stored copies described here. Similarly, we did not observe an overall detrimental trend in the library QC data for the hydrated-DMSO samples compared with samples prepared with DMSO alone in either working or stored copies.
Correlation of LC-MS results with CYP assay results
We next examined whether outlier compounds that showed anomalous potencies correlated with lower QC results. Of the 51 outliers observed from the CYP 1A2 assay in the DMSOworking copy, 31 (60%) were found by LC-MS as having a decrease in purity between samples from the stored copy and the working copy, with 5 compounds of the 51 not found in both plate copies. From a copy of 207 compounds showing decreases in potency, the number of compounds in which a decrease in purity was measured by LC-MS totaled 84 (41%), whereas 100 (50%) were characterized as 100% pure both before and after the experiment. The remaining compounds were either not found by LC-MS in either plate copy (n = 20) or showed an apparent increase in purity (n = 3). For the CYP 2D6 assay against the DMSO copies, of the 74 total outliers observed, 32 were found to have a decrease in purity (43%), 33 were found at full purity in both plate copies (45%), 5 showed an apparent increase in purity, and 4 were not found by QC in either copy. In the hydrated-DMSO copies, we noted that of the 44 outliers observed in the CYP 1A2 experiment, only 10 (23%) compounds showed a decrease in purity, with 28 (64%) at full purity in both stored and working plate sets. Three were not found by QC, and another 3 showed an apparent increase in purity. A similar distribution was found in the CYP 2D6 experiment, in which of 58 outliers, 14 (28%) compounds decreased in purity and 39 (67%) were found at full purity in both stored and working plate sets. Two were not found, and 3 showed an apparent increase in purity. From this, it is evident that changes in compound purity measured with LC-MS do not necessarily predict variable CYP assay performance, perhaps because of degradation products acting as inhibitors of the CYP enzyme. However, this result also underscores the need to measure concentration in analytical library QC procedures, as this would allow one to address losses in potencies due to precipitation of the compound. 
Positional effects
The working library plates in this experiment used 4-column flanking regions (the first 4 columns were reserved for controls) and 4 trailing rows (compound free/DMSO only) along the long dimension of the plate. A platewise comparison of wells with outlier compounds at any point during the experiment did not show an obvious pattern, for example, a tendency for compounds stored near the plate edges to display high activity variability (data not shown). However, we note that edge effects may have been more readily determined if a P450 isozyme such as CYP 3A4 was used, as was recently demonstrated by Turner and coworkers 39 in a study of nanospots formatted to 1536-and 3456-well plates.
SUMMARY
We have shown how the reproducibility of potency values can change over time due to sample storage conditions. From this study, we would recommend storage of 1536-well compound library plates at room temperature for <4 months. In agreement with other studies, samples stored at low temperature (-80 °C) showed better performance in the QC study then samples stored at room temperature. The Prestwick library used in this evaluation contains known drugs. Although there is certainly an increased effort to make compound libraries more "druglike," the optimal storage time may be different for other types of compound collections. The spot checking of compound libraries using P450 assays as described here may serve as a useful tool for QC in addition to analytical chemistry-profiling methods. Finally, our study found that differences, as measured by traditional QC methods and 2 robust bioassays, between plates prepared in either hydrated-DMSO or DMSO were small. It is likely that the DMSO-prepared plates achieved the hydrated conditions within a short time frame. Therefore, for collections of compounds with druglike properties, based on the data from the two P450 assays described here, preparation of plates with hydrated-DMSO followed by room temperature storage will (214); dark gray: purity 50% to 95% (100); black: purity <50% (34); white: purity >95% (769). (C) Working compound library plates stored in ambient saturated DMSO atmosphere for 37 weeks. Light gray: samples not found (354); dark gray: purity 50% to 95% (159); black: purity <50% (147); white: purity >95% (457). (D) Hydrated-DMSO copy heat sealed and stored at -80 °C for 37 weeks. Light gray: samples not found (189); dark gray: purity 50% to 95% (74); black: purity <50% (31); white: purity >95% (787). (E) Hydrated-DMSO working compound library plates stored in ambient atmosphere for 37 weeks. Light gray: samples not found (331); dark gray: purity 50% to 95% (136); black: purity <50% (67); white: purity >95% (583). The total amount of samples found is represented by the underlying gray shaded area for each condition. The number of not-found samples in the supplied set is 252. These samples were consistently not found in the other determinations with overlaps of 72.6% (183/252): DMSO-stored, 84.1% (212/252): DMSOworking, 75.4% (190/252): hydrated-DMSO stored, and 81% (204/252): hydrated-DMSO working observed for these conditions.
